METASTASES
Clinical trials for METASTASES explained in plain language.
Never miss a new study
Get alerted when new METASTASES trials appear
Sign up with your email to follow new studies for METASTASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug 'Unmasks' cancer cells to immune system in early trial
Disease control Not yet recruitingThis early-phase trial tests a new drug that helps the immune system recognize and attack cancer cells by blocking a 'don't eat me' signal. It is for people with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the ri…
Matched conditions: METASTASES
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New combo approach may extend life for advanced liver cancer patients
Disease control Not yet recruitingThis study looks at people with liver cancer that has spread to a few spots outside the liver. All participants first get a combination of two drugs (sintilimab and lenvatinib). Those whose cancer is controlled are then randomly assigned to either continue the drugs alone or also…
Matched conditions: METASTASES
Phase: PHASE3 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Exercise program aims to boost strength and quality of life in advanced breast cancer
Symptom relief Not yet recruitingThis study looks at whether a structured exercise program can help women with stage IV (metastatic) breast cancer improve their physical function, fitness, and quality of life. About 78 women currently on treatment will take part. The program focuses on walking, strength, and bod…
Matched conditions: METASTASES
Phase: NA • Sponsor: State University of Londrina • Aim: Symptom relief
Last updated May 17, 2026 03:11 UTC
-
Can a stronger radiation dose help patients with large tumors?
Symptom relief Not yet recruitingThis study compares standard palliative radiotherapy (24 Gray in 3 sessions) with a higher dose (27 Gray in 3 sessions) for patients with bulky metastatic cancer that has spread. The goal is to see if the higher dose improves local tumor control and survival. About 20 adults with…
Matched conditions: METASTASES
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC